Insulin Glargine (Glaritus)
| Product Overview | |
| Generic Name | Insulin Glargine (Glaritus) |
| Brand Name(s) | Glaritus |
| Form | Vial 10mL |
| Strength | 100iu/mL standard long-acting |
| Therapeutic Class | Antidiabetic; long-acting insulin analogue |
| ATC Code | A10AE04 |
| Manufacturing & Regulatory | |
| Manufacturer | Wockhardt Ltd, India |
| Country | India |
| GMP Compliance | WHO‑GMP |
| DMF/CEP | Not applicable; under Indian dossier |
| COFEPRIS | 010.000.04158.03.01 |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 5,000 units |
| Shelf Life | 24 months |
| Storage | 2–8 °C, protect from light |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Yes |
| SDS | Upon Request |
| CTD Summary | Upon Request |
Description
Indications & Usage Once‑daily basal insulin for type 1 and type 2 diabetes mellitus in adults and children (≥2 years) requiring basal insulin
